The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInter. Pers. Regulatory News (IPF)

Share Price Information for Inter. Pers. (IPF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 110.00
Bid: 108.50
Ask: 110.00
Change: 0.50 (0.46%)
Spread: 1.50 (1.382%)
Open: 109.50
High: 110.00
Low: 108.50
Prev. Close: 109.50
IPF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pricing of New Notes

20 Oct 2020 07:00

RNS Number : 5444C
International Personal Finance Plc
20 October 2020
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (THE "UNITED STATES") OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933) OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT (SEE "OFFER AND DISTRIBUTION RESTRICTIONS" IN THE EUR OFFER MEMORANDUM REFERRED TO BELOW).

International Personal Finance plc (IPF) specialises in providing unsecured consumer credit to more than 1.7 million customers across 10 markets. IPF operates the world's largest home credit business and a leading fintech business, IPF Digital.

INTERNATIONAL PERSONAL FINANCE PLC ANNOUNCES PRICING OF NEW NOTES

INTERNATIONAL PERSONAL FINANCE PLC

(incorporated with limited liability in England and Wales with registered number 06018973)(the "Issuer" or "IPF")

EUR 412,000,000 5.75 per cent. Senior Unsecured Unsubordinated Fixed Rate Notes due 2021

(the "Existing EUR Notes")

On 14 October 2020, IPF announced an Exchange Offer in respect of the Existing EUR Notes on the terms set out in an offer memorandum dated 14 October 2020 (the "EUR Offer Memorandum").

The purpose of the Exchange Offer is to extend the maturity profile of part of the Issuer's debt financing in line with IPF's half-year report dated 8 September 2020, where IPF stated that "we are mindful of the April 2021 maturity of our Eurobond". The Exchange Offer provides Noteholders with the opportunity to exchange their holdings of the Existing Notes for new euro denominated notes with a maturity of five years to be issued by the Issuer (the "New Notes") or, in certain circumstances, a combination of New Notes and cash as more fully set out in the EUR Offer Memorandum.

In connection with the Exchange Offer, IPF is pleased to announce that the New Notes which form part of the exchange consideration will bear interest at the rate of 9.75 per cent. per annum, payable annually in arrear and the New Notes will be issued at an issue price of 99.00 per cent. of their nominal amount. Unless previously redeemed or purchased and cancelled, the New Notes will be redeemed at 100 per cent. of their nominal amount, together with any accrued and unpaid interest, on their maturity date in November 2025.

To offer Existing EUR Notes in the Exchange Offer, a holder of the Existing EUR Notes should deliver, or arrange to have delivered on its behalf, via the relevant Clearing System and in accordance with the requirements of such Clearing System, a valid Exchange Instruction to be received by the Exchange and Tabulation Agent by 4.00 p.m. (London time) on 3 November 2020 (the "Final Deadline"). To be eligible for the Early Exchange Consideration, such Exchange Instruction must be received by the Exchange and Tabulation Agent on or before 4.00 p.m. (London time) on 28 October 2020 (the "Early Deadline").

Exchange Instructions will be irrevocable except in the limited circumstances described in the EUR Offer Memorandum under the heading "Amendment and Termination".

The following indicative timetable sets out the expected dates and times of the key events in relation to the Exchange Offer. This is subject to change and will depend, among other things, on timely receipt of Exchange Instructions in respect of the Existing EUR Notes.

Date and time

Event

28 October 2020 at 4.00 p.m.

(London time)

Early Deadline

3 November 2020 at 4.00 p.m.

(London time)

Final Deadline

5 November 2020 at 4.00 p.m.

(London time) onwards

EUR Meetings

Expected to be as soon as

reasonably practicable

after the EUR Meetings

Announcement of conditional acceptance of Existing EUR Notes exchanged pursuant to the Exchange Offer

As soon as reasonably

practicable after the EUR Meetings

Execution of the Supplemental Trust Deed(s) implementing the amendments to the conditions of the Existing EUR Notes

Expected to be no later than 5 business days after the passing of the Extraordinary Resolutions (subject, in the case of each Invitation, to satisfaction and/or (if applicable) waiver of any conditions to settlement)

Settlement Date

 

Terms used, but not otherwise defined, in this announcement shall have the meaning given to them in the RNS announcement made by IPF on 14 October 2020 with RNS number 0374C. For the purposes of the EUR Offer Memorandum, this is an Exchange Offer Announcement.

An overview of the key terms of the Exchange Offer is available on IPF's website - www.ipfin.co.uk 

The EUR Offer Memorandum and related materials can be accessed by Noteholders via the Exchange and Tabulation Agent's website - https://portal.lucid-is.com

Questions and requests for assistance in connection with the Exchange Offer may be directed to the EUR Dealer Managers

EUR JOINT DEALER MANAGERS

Banco Santander, S.A. - London Branch2 Triton SquareRegent's PlaceLondon NW1 3ANUnited Kingdom

Telephone: + 44 20 7756 6909 / +44 20 7756 6227Email: Tommaso.GrosPietro@santanderCIB.co.uk / Adam.Crocker@santandercib.co.ukAttention: Liability Management

HSBC Bank plc8 Canada SquareLondon E14 5HQUnited Kingdom

Telephone: +44 20 7992 6237Email: LM_EMEA@hsbc.comAttention: Liability Management

Jefferies International Limited100 BishopsgateLondon EC2N 4JLUnited Kingdom

Telephone: +44 (0) 20 7548 4313 Email: EMEA_FI_CapitalMarkets@jefferies.comAttention: Debt Capital Markets

EUR CO-DEALER MANAGERS

ABG Sundal Collier ABRegeringsgatan 25Stockholm 111 53Sweden

Attention: Kristoffer OhrnEmail: Kristoffer.Ohrn@abgsc.se

Peel Hunt LLPMoor House120 London WallLondon EC2Y 5ETUnited Kingdom

Attention: Debt Capital MarketsEmail: ipf-dcm@peelhunt.com

Questions and requests for assistance in connection with the delivery of Exchange Instructions may be directed to the Exchange and Tabulation Agent

EXCHANGE AND TABULATION AGENT

Lucid Issuer Services LimitedTankerton Works12 Argyle WalkLondon WC1H 8HAUnited Kingdom

Telephone: +44 20 7704 0880Attention: David Shilson / Owen MorrisEmail: ipfin@lucid-is.com

This announcement is released by International Personal Finance plc and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), encompassing information relating to the New Notes offered in exchange for the Existing Notes. For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by James Ormrod at International Personal Finance plc.

A copy of this statement can be found on our website - www.ipfin.co.uk

Legal Entity Identifier: 213800II1O44IRKUZB59

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPGWWUUPUPGB
Date   Source Headline
2nd May 20241:53 pmRNSResults of AGM
2nd May 20247:00 amRNSQ1 2024 Trading Update
1st May 20246:01 pmRNSBoard Committee Membership Changes
1st May 20246:00 pmRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSTotal Voting Rights
8th Apr 20241:13 pmRNSDirector/PDMR Shareholding
5th Apr 202410:00 amRNSDirector/PDMR Shareholding
4th Apr 202410:48 amRNSDirector/PDMR Shareholding
3rd Apr 20243:29 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
27th Mar 20245:09 pmRNSDirector/PDMR Shareholding
25th Mar 20244:44 pmRNSAnnual Financial Report and Notice of AGM
21st Mar 20245:09 pmRNSDirector/PDMR Shareholding
19th Mar 20243:56 pmRNSDirector/PDMR Shareholding
18th Mar 20244:11 pmRNSDirector/PDMR Shareholding
15th Mar 202410:38 amRNSFinal Dividend Timetable Correction
14th Mar 20247:00 amRNSFinal Results and Accounts
26th Feb 20247:00 amRNSDelay of year-end results announcement
8th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Dec 20239:08 amRNSHolding(s) in Company
14th Dec 202311:24 amRNSPublication of Final Terms
24th Nov 20237:02 amRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSFinal Confirmation & Results of Exchange Offer
17th Nov 20233:18 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSAppointment of Joint Broker
14th Nov 20233:09 pmRNSHolding(s) in Company
8th Nov 20237:00 amRNSNotice of Investor Webinar - 7 December 2023
3rd Nov 20234:14 pmRNSIssuance and amendment to Final Terms
2nd Nov 20231:29 pmRNSCash Offer Launch
2nd Nov 20231:18 pmRNSExchange Offer
2nd Nov 20231:16 pmRNSPublication of a Prospectus
26th Oct 20237:01 amRNSRoadshow Announcement
26th Oct 20237:00 amRNSQ3 2023 Trading Update
25th Oct 20232:12 pmRNSChange of Senior Independent Director
24th Oct 20233:19 pmRNSPublication of Final Terms - Replacement Notice
24th Oct 20237:00 amRNSPublication of Final Terms
20th Oct 20237:00 amRNSUpdate on Annual General Meeting 2023 Vote
2nd Oct 20237:00 amRNSTotal Voting Rights
14th Sep 20231:46 pmRNSDirector/PDMR Shareholding
1st Sep 20237:00 amRNSTotal Voting Rights
24th Aug 20234:35 pmRNSPublication of a Prospectus
1st Aug 20237:00 amRNSHalf-year Report
13th Jul 202311:14 amRNSHolding(s) in Company
3rd Jul 20232:30 pmRNSTotal Voting Rights
3rd Jul 20239:20 amRNSBlock listing Interim Review
1st Jun 20237:00 amRNSTotal Voting Rights
11th May 20234:48 pmRNSDirector/PDMR Shareholding
4th May 202311:17 amRNSDirector/PDMR Shareholding
2nd May 202312:28 pmRNSTotal Voting Rights
27th Apr 20234:27 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.